Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site

Detalles Bibliográficos
Autores principales: Schwartz, Zander, Zhao, Piao, Wang, Annie, Zhao, Guozhi, Zeng, Wei, Wang, Yonghui, Luu, Hue H., Haydon, Rex C., He, Tong-Chuan, Reid, Russell R., Strelzow, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2022
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201659/
https://www.ncbi.nlm.nih.gov/pubmed/37223510
http://dx.doi.org/10.1016/j.gendis.2022.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201659/
https://www.ncbi.nlm.nih.gov/pubmed/37223510
http://dx.doi.org/10.1016/j.gendis.2022.09.001

Ejemplares similares